135 related articles for article (PubMed ID: 26723084)
1. Proton radiotherapy for primary liver cancers.
Granovetter M
Lancet Oncol; 2016 Feb; 17(2):e49. PubMed ID: 26723084
[No Abstract] [Full Text] [Related]
2. Proton beam therapy for tumors of the upper abdomen.
Raldow A; Lamb J; Hong T
Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Therapy in Liver Malignancies.
Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
[TBL] [Abstract][Full Text] [Related]
4. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
5. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wo JY; Dawson LA; Zhu AX; Hong TS
Surg Oncol Clin N Am; 2014 Apr; 23(2):353-68. PubMed ID: 24560114
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.
Lo EC; N Rucker A; Federle MP
Semin Radiat Oncol; 2018 Oct; 28(4):267-276. PubMed ID: 30309637
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma.
Shindoh J
Ann Surg Oncol; 2020 Apr; 27(4):983-984. PubMed ID: 31848809
[No Abstract] [Full Text] [Related]
8. The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
Spreafico C; Maccauro M; Mazzaferro V; Chiesa C
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):634-8. PubMed ID: 24477451
[No Abstract] [Full Text] [Related]
9. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
[TBL] [Abstract][Full Text] [Related]
10. Individualised adaptive radiotherapy in liver cancer.
Das M
Lancet Oncol; 2017 Sep; 18(9):e520. PubMed ID: 28826591
[No Abstract] [Full Text] [Related]
11. Radiation therapy for liver tumors: ready for inclusion in guidelines?
Tanguturi SK; Wo JY; Zhu AX; Dawson LA; Hong TS
Oncologist; 2014 Aug; 19(8):868-79. PubMed ID: 25001265
[TBL] [Abstract][Full Text] [Related]
12. Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer.
Rim CH; Park S; Woo JY; Seong J
Strahlenther Onkol; 2018 Nov; 194(11):1017-1029. PubMed ID: 30105451
[TBL] [Abstract][Full Text] [Related]
13. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
[TBL] [Abstract][Full Text] [Related]
14. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
[TBL] [Abstract][Full Text] [Related]
15. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
Hamamoto Y; Niino K; Ishiyama H; Hosoya T
Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
[TBL] [Abstract][Full Text] [Related]
17. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.
Beddar AS; Briere TM; Balter P; Pan T; Tolani N; Ng C; Szklaruk J; Krishnan S
Radiother Oncol; 2008 Jun; 87(3):445-8. PubMed ID: 18194819
[TBL] [Abstract][Full Text] [Related]
18. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
Apisarnthanarax S; Bowen SR; Combs SE
Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
[TBL] [Abstract][Full Text] [Related]
19. Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation.
Tai A; Erickson B; Khater KA; Li XA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):900-7. PubMed ID: 18262101
[TBL] [Abstract][Full Text] [Related]
20. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
